Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Trueblue ( (TBI) ) has provided an update.
On May 14, 2025, TrueBlue, Inc. held its annual meeting of shareholders where 27,085,588 shares were represented. During the meeting, shareholders elected nine directors, approved executive compensation, amended the 2016 Omnibus Incentive Plan, and ratified Deloitte & Touche LLP as the accounting firm for the fiscal year ending December 28, 2025.
The most recent analyst rating on (TBI) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Trueblue stock, see the TBI Stock Forecast page.
Spark’s Take on TBI Stock
According to Spark, TipRanks’ AI Analyst, TBI is a Neutral.
Trueblue’s overall stock score reflects significant financial and technical challenges, as evidenced by declining revenues and bearish market indicators. While strategic initiatives and cost management offer some optimism, the substantial revenue declines and net losses pose substantial risks. The unattractive valuation further weighs down the stock’s appeal.
To see Spark’s full report on TBI stock, click here.
More about Trueblue
Average Trading Volume: 337,137
Technical Sentiment Signal: Sell
Current Market Cap: $158.6M
See more insights into TBI stock on TipRanks’ Stock Analysis page.